5 completed, 1 terminated. 2 Phase 3, 1 Not applicable, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Terminated 1 |
Follow RA: new trials by email Literature Review of RA trials Research Report on RA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PET-Based Imaging of Radiolabeled CIT-013 [89Zr]Zr-CIT - RA | Phase 2 | Completed | Citryll BV | 7 | 2026-01-15 | 2026-10-19 |
| Effects of Tofacitinib vs Methotrexate on Rheumatoid Arthritis Interstitial Lung Disease Tofacitinib, Methotrexate - Rheumatoid Arthritis, Interstitial Lung Disease Due to Systemic Disease (Disorder) | Phase 4 | Terminated | Vastra Gotaland Region | 3 | 2020-11-07 | 2024-05-23 |
| Auto-injector Real Life Handling in Patients Adalimumab - RA | Phase 3 | Completed | Alvotech Swiss AG | 107 | 2019-11-04 | 2022-05-05 |
| Surgical Tourniquets and Cerebral Emboli Osteoarthritis, RA | Completed | University Hospitals Coventry and Warwickshire NHS Trust | 12 | 2014-09-01 | 2015-06-30 | |
| To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis Sarilumab, Auto-Injector Device (AID), Pre-filled Syringe (PFS) - RA | Phase 3 | Completed | Sanofi | 217 | 2014-03-01 | 2017-06-20 |
| Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody Response 0,5 mg Prevenar i.m., 0,5 mg seasonal influenza vaccine i.m. - RA, SLE | Not applicable | Completed | Region Skane | 300 | 2011-10-01 | 2018-10-03 |
Arthritis, Rheumatoid (1) · Disease (1) · Lung Diseases, Interstitial (1) · Osteoarthritis (1) · Scleroderma, Diffuse (1) · Syndrome (1) · Vasculitis (1) · Wounds and Injuries (1)
Arthritis (2) · Connective Tissue Diseases (2) · Joint Diseases (2) · Musculoskeletal Diseases (2) · Rheumatic Diseases (2) · Skin and Connective Tissue Diseases (2) · Autoimmune Diseases (1) · Cardiovascular Diseases (1) · Immune System Diseases (1) · Lung Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Respiratory Tract Diseases (1) · Scleroderma, Systemic (1) · Skin Diseases (1)
Methotrexate (2) · Adalimumab (1) · Hydroxychloroquine (1) · Leflunomide (1) · Sulfasalazine (1) · sarilumab (1) · tofacitinib (1)
Alvotech Swiss AG (1) · Citryll BV (1) · Region Skane (1) · Sanofi (1) · University Hospitals Coventry and Warwickshire NHS Trust (1) · Vastra Gotaland Region (1)
Sweden (2) · Chile (1) · Georgia (1) · Mexico (1) · Netherlands (1) · Poland (1) · Russia (1) · South Africa (1) · Ukraine (1) · United Kingdom (1) · United States (1)
Anna-Karin H Ekwall, MD MSc PhD (1) · Jehns Martineus, MD (1) · Meliha C Kapetanovic, MD, PhD (1) · Nemanja Damjanov, Prof (1) · Victoria Gibbs, BA, MBBS (1)
PMID 28081972, PMID 28552512, PMID 29209946, PMID 29325173, PMID 30886963, PMID 36205514